Robert Z. Orlowski
@Myeloma_Doc
Director of Myeloma Section at MD Anderson Cancer Center; Translational researcher who hates myeloma. Tweets are my own. Retweets ≠ endorsements.
06-09-2010 00:32:59
40,5K Tweets
15,0K Followers
2,5K Following
#Myeloma Paper of the Day: Study of real world impact of bridging therapy prior to CAR T finds response showed no significant association with CRS, ICANS rates, or 3-month post-CAR-T response, and median PFS didn’t significantly differ based on response: pubmed.ncbi.nlm.nih.gov/38609386/.
